Gujarat Themis Biosyn Limited has informed the Exchange about General Updates
GUJTHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gujarat Themis Biosyn Limited has incorporated a new wholly owned subsidiary named 'Themis Biosyn Japan Limited' in Japan. The subsidiary was incorporated on 19th May 2026 with a share capital of Ten Lakhs Yen (approximately 10 Lakhs). The new entity will operate in the pharmaceutical industry. Gujarat Themis Biosyn holds 100% of the shareholding in this newly formed subsidiary. This move represents the company's first step towards establishing a direct presence in the Japanese market.
Positive for shareholders as it indicates international expansion into Japan's pharmaceutical market. However, being a newly incorporated entity with no operational history, the financial impact will likely be neutral in the near term.